Omeros Corporation (OMER) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.34B, a trailing price-to-earnings ratio of 5.3 and a free-cash-flow yield of -9.9%. Nama's AI scorecard rates it Hold, 4.5 out of 10. On 12-month momentum it ranks in the leading band of its market.
AI scorecard
Hold · 4.5/10
The sections balance, or too few of them graded to call it either way. As of Oct 2, 2026.
Momentum
Leading · +346.9% over 12 months ex. last
Top 20% of its market on the past year's move, per unit of the stock's own swings.
Shariah screen
Can't Tell
A figure the screen needs is missing — most often Yahoo carries no interest-income row for the company — so no ratio failed and none could be confirmed.
Off its high
-12.4%
How far the last close sits under the highest price of the past five years.
Market cap
$1.34B
Trailing P/E
5.3
Price / book
—
Price / sales
34.9
FCF yield
-9.9%
Dividend yield
—
Gross margin
96.4%
Operating margin
-189.5%
Net margin
324.9%
Revenue growth (YoY)
—
Revenue growth (3-yr annual)
—
EPS growth (YoY)
—
FCF/share growth (YoY)
—
Beta
2.6
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
OMER earnings
Next report: Nov 12, 2026 (Q3 2026, EPS estimate -$0.02).
Beat the EPS estimate in 4 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q2 2026
Aug 12, 2026
$0.10
-$0.33
+130.3%
$28.53M
Q1 2026
May 13, 2026
$0.57
-$0.39
+246.2%
$9.89M
Q4 2025
Mar 31, 2026
$3.14
$2.24
+40.2%
$0
Q3 2025
Nov 13, 2025
-$0.32
-$0.48
+33.3%
$0
OMER analyst price target
Median target $27.50 from 2 analysts, ranging $22.00 – $33.00.
Nama's AI scorecard currently rates Omeros Corporation Hold (4.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is OMER's P/E ratio?
Omeros Corporation trades at a trailing price-to-earnings ratio of 5.3.
When does OMER report earnings?
Omeros Corporation's next scheduled report is on Nov 12, 2026. Analysts expect EPS of -$0.02.
What is the OMER price target?
The median analyst price target from 2 analysts is $27.50, with a range of $22.00 – $33.00.
Is OMER Shariah compliant?
Nama's AAOIFI-style screen reads Omeros Corporation as Can't Tell. A figure the screen needs is missing — most often Yahoo carries no interest-income row for the company — so no ratio failed and none could be confirmed.